MariMed Inc. (MRMD.CN)
CAD 0.15
(0.0%)
CAD 0.15
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.38 Million USD | -29.38% |
| 2022 | 20.36 Million USD | -24.18% |
| 2021 | 26.86 Million USD | 84.87% |
| 2020 | 14.53 Million USD | 159.28% |
| 2019 | 5.6 Million USD | 239.26% |
| 2018 | -4.02 Million USD | -433.71% |
| 2017 | 1.2 Million USD | 97.13% |
| 2016 | 611.73 Thousand USD | 136.18% |
| 2015 | -1.69 Million USD | -106.84% |
| 2014 | -817.34 Thousand USD | -46.44% |
| 2013 | -558.14 Thousand USD | 27.96% |
| 2012 | -774.78 Thousand USD | -107.35% |
| 2011 | -373.66 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 956 Thousand USD | -52.7% |
| 2024 Q1 | 2.02 Million USD | -16.18% |
| 2023 Q2 | 3.54 Million USD | 20.77% |
| 2023 Q4 | 2.41 Million USD | -26.76% |
| 2023 Q1 | 2.93 Million USD | -47.06% |
| 2023 Q3 | 3.29 Million USD | -7.19% |
| 2023 FY | 14.38 Million USD | -29.38% |
| 2022 Q1 | 7.04 Million USD | 485.49% |
| 2022 Q3 | 5.73 Million USD | 27.61% |
| 2022 Q4 | 5.54 Million USD | -3.28% |
| 2022 FY | 20.36 Million USD | -24.18% |
| 2022 Q2 | 4.49 Million USD | -36.23% |
| 2021 Q2 | 12 Million USD | 70.52% |
| 2021 Q4 | 1.2 Million USD | -81.81% |
| 2021 Q1 | 7.03 Million USD | -12.45% |
| 2021 FY | 26.86 Million USD | 84.87% |
| 2021 Q3 | 6.61 Million USD | -44.85% |
| 2020 FY | 14.53 Million USD | 159.28% |
| 2020 Q1 | 994.4 Thousand USD | 102.08% |
| 2020 Q2 | 2.09 Million USD | 111.11% |
| 2020 Q3 | 3.39 Million USD | 61.87% |
| 2020 Q4 | 8.03 Million USD | 136.57% |
| 2019 Q1 | -222.28 Thousand USD | 96.96% |
| 2019 Q4 | -47.7 Million USD | -5005.06% |
| 2019 Q3 | 972.62 Thousand USD | -81.82% |
| 2019 FY | 5.6 Million USD | 239.26% |
| 2019 Q2 | 5.34 Million USD | 2506.63% |
| 2018 Q2 | 846.22 Thousand USD | 236.92% |
| 2018 Q4 | -7.31 Million USD | -949.6% |
| 2018 Q1 | 251.16 Thousand USD | 131.52% |
| 2018 FY | -4.02 Million USD | -433.71% |
| 2018 Q3 | 860.92 Thousand USD | 1.74% |
| 2017 FY | 1.2 Million USD | 97.13% |
| 2017 Q4 | 108.48 Thousand USD | -62.21% |
| 2017 Q1 | 209.25 Thousand USD | -53.18% |
| 2017 Q2 | 601.11 Thousand USD | 187.26% |
| 2017 Q3 | 287.04 Thousand USD | -52.25% |
| 2016 Q1 | 14.54 Thousand USD | 101.4% |
| 2016 FY | 611.73 Thousand USD | 136.18% |
| 2016 Q4 | 446.94 Thousand USD | 712.08% |
| 2016 Q3 | 55.03 Thousand USD | -43.96% |
| 2016 Q2 | 98.2 Thousand USD | 575.07% |
| 2015 Q1 | -289.1 Thousand USD | 40.42% |
| 2015 Q3 | 6280.00 USD | 101.69% |
| 2015 FY | -1.69 Million USD | -106.84% |
| 2015 Q4 | -1.03 Million USD | -16588.11% |
| 2015 Q2 | -372.29 Thousand USD | -28.77% |
| 2014 Q4 | -485.2 Thousand USD | -404.73% |
| 2014 FY | -817.34 Thousand USD | -46.44% |
| 2014 Q3 | -96.13 Thousand USD | 2.16% |
| 2014 Q2 | -98.25 Thousand USD | 28.68% |
| 2014 Q1 | -137.75 Thousand USD | 15.47% |
| 2013 Q3 | -95.95 Thousand USD | 24.29% |
| 2013 Q4 | -162.97 Thousand USD | -69.84% |
| 2013 FY | -558.14 Thousand USD | 27.96% |
| 2013 Q1 | -172.47 Thousand USD | 55.83% |
| 2013 Q2 | -126.74 Thousand USD | 26.52% |
| 2012 Q3 | -171.97 Thousand USD | -23.15% |
| 2012 Q4 | -390.52 Thousand USD | -127.09% |
| 2012 Q2 | -139.64 Thousand USD | -92.24% |
| 2012 Q1 | -72.64 Thousand USD | 0.0% |
| 2012 FY | -774.78 Thousand USD | -107.35% |
| 2011 Q2 | -266.95 Thousand USD | 0.0% |
| 2011 FY | -373.66 Thousand USD | 0.0% |
| 2011 Q3 | -98.35 Thousand USD | 63.16% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | 1307.86% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | 542.496% |
| Blueberries Medical Corp. | -1.22 Million CAD | 1272.783% |
| The BC Bud Corporation | -1.22 Million CAD | 1275.746% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 325.92% |
| CordovaCann Corp. | -2.51 Million CAD | 672.524% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | 1733.642% |
| Captor Capital Corp. | 655.2 Thousand CAD | -2095.483% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | 1543.625% |
| 1CM Inc. | 300.79 Thousand CAD | -4682.39% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | 2707.358% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 470.834% |
| IM Cannabis Corp. | -12.17 Million CAD | 218.152% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 528.203% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 3767.622% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 551.507% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | -2552.738% |
| Ovation Science Inc. | -764 Thousand CAD | 1982.834% |
| Pharmadrug Inc. | -1.33 Million CAD | 1177.518% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | 1359.66% |
| RAMM Pharma Corp. | -7.08 Million CAD | 303.002% |
| RIV Capital Inc. | 1.78 Million CAD | -708.038% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 537.76% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 264.043% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 340.294% |
| 1933 Industries Inc. | -9.34 Million CAD | 253.862% |
| Red Light Holland Corp. | -6.44 Million CAD | 323.147% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | 1932.946% |
| Xebra Brands Ltd. | -1.55 Million CAD | 1025.355% |
| Adastra Holdings Ltd. | -1.79 Million CAD | 901.947% |